ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.53B
- Beta
- 0.00
Volume 0.70M
Average 1.06M
ADRX Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Operating Margin history
Percent of revenue · from the income statement
No Operating Margin data reported for this period type.
Operating Margin vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | -131.9% | +329.0 pp | +600.7 pp | |
| LTM Mar 2026 | -196.7% | -136.0 pp | -117.4 pp | |
| LTM Mar 2026 | -274.2% | -154.4 pp | +3955.2 pp | |
| LTM Mar 2026 | -345.5% | -170.5 pp | +1537.1 pp | |
| FY2025 | -412.6% | — | — | |
| LTM Mar 2026 | -577.5% | -597.5 pp | +830.1 pp | |
| LTM Mar 2026 | -5121.8% | +247.9 pp | — | |
| LTM Mar 2026 | -9396.6% | — | -15774.1 pp | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — |
| FY2025 | — | — | — | |
| Peer median (excluding ADRX) | -379.0% | -145.2 pp | +715.4 pp | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$13.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.